All regulations
Nonrulemaking
FDA
FDA-2026-N-3500
Notice of Approval of Product Under Priority Review Voucher; Material Threat Medical Countermeasure Priority Review Voucher; MRESVIA (Respiratory Syncytial Virus Vaccine)
Documents
1
Comments
0
Documents
Keywords
2025-59
CBER
Notice of Approval of
Product Under Priority Review Voucher
Material Threat Medical
Countermeasure Priority Review Voucher
MRESVIA
Respiratory Syncytial Virus Vaccine
Data from Regulations.gov